BLOGBU$TER
Description
excerpt from site's contentPrimary Menu Search for Roche will stop its Phase III study with MetMab in combi with Tarceva in patients with non-small cell lung cancer for lack of efficacy An independent data monitoring committee recommended that the study be stopped MetMab is a c-Met inhibitor and Tarceva targets EGFr This is where the power of G...
This is an automatically generated AboutUs page for BlogBuster.org. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
